Efficacy and tolerability of ADHD medications in a clinical practice

Journal of Pediatric Neurology

Volumn 6, Issue 1, 2008, Pages 5-10

  Miller Horn, Jill W ^a   Kaleyias, Joseph ^a   Valencia, Ignacio ^a   Melvin, Joseph J ^a   Khurana, Divya S ^a   Hardison, H Huntley ^a   Marks, Harold ^a   Legido, Agustin ^a   Kothare, Sanjeev V ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

ADHD; Children; Efficacy; Non stimulants; Side effect; Stimulants; Tolerability

Indexed keywords

AMPHETAMINE; ATOMOXETINE; METHYLPHENIDATE;

ADOLESCENT; ADOLESCENT DISEASE; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CHILDHOOD DISEASE; CLINICAL PRACTICE; DECREASED APPETITE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OPEN STUDY; OUTCOME ASSESSMENT; OUTPATIENT CARE; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TIC;

EID: 41849135015     PISSN: 13042580     EISSN: 18759041     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th ed). Text Revision. Washington, DC: American Psychiatric Association, 2000.
2. C.J. Kratochvil, J.H. Heiligenstein, R. Dittmann et al., Atomoxetine and methylphenidate treatment in children with ADHD: A prospective, randomized, open-label trial, J Am Acad Child Adolesc Psychiatry 41 (2002), 776-784.
3. The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder, Arch Gen Psychiatry 56 (1999), 1073-1086.
4. J.S. Markowitz, A.D. Straughn and K.S. Patrick, Advances in the pharmacotherapy of attention-deficit-hyperactivity disorder: Focus on methylphenidate formulations, Pharmacotherapy 23 (2003), 1281-1299.
5. S. Pliszka, AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder, J Am Acad Child Adolesc Psychiatry 46 (2007), 894-921.
6. P.S. Jensen, S.P. Hinshaw, J.M. Swanson et al., Findings from the NIMH Multimodal treatment study of ADHD (MTA): Implications and applications for primary care providers, J Dev Behav Pediatr 22 (2001), 60-73.
7. K.C. Daley, Update on attention-deficit/hyperactivity disorder, Curr Opin Pediatr 16 (2004), 217-226.
8. K.K. Voeller, Attention-deficit hyperactivity disorder (ADHD), J Child Neurol 19 (2004), 798-814.
9. J. Dopheide, ASHP therapeutic position statement on the appropriate use of medications in the treatment of attention-deficit/hyperactivity disorder in pediatric patients, Am J Health Syst Pharm 62 (2005), 1502-1509.
10. J. Elia, P.J. Ambrosini and J.L. Rapoport, Treatment of attention deficit-hyperactivity disorder, N Engl J Med 340 (1999), 780-788.
11. J.J. McGough, J. Biederman, L.L. Greenhill et al., Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall, J Am Acad Child Adolesc Psychiatry 42 (2003), 684-691.
12. T. Spencer, J. Biederman, T. Wilens, M. Harding, D. O'Donnell and S. Griffen, Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle, J Am Acad Child Adolesc Psychiatry 35 (1996), 409-432.
13. American Academy of Pediatrics, Committee on Quality Improvement and Subcommittee on Attention-Deficit/Hyperactivity Disorder. Clinical practice guideline: Treatment of the school-aged child with attention-deficit/hyperactivity disorder, Pediatrics 108 (2001), 1033-1044.
14. Attention Deficit Hyperactivity Disorder Algorithm. Available At: Texas Department of State Health Services Website www.dshs.state.tx.us/ mhprograms/ADHD_Algo_Schematics_With_NO_Sig_Co_Dis.pdf.
15. D.F. Connor, Preschool attention deficit hyperactivity disorder: A review of prevalence, diagnosis, neurobiology, and stimulant treatment, J Dev Behav Pediatr 23 (2002), S1-S9.
16. S.V. Faraone, J. Biederman and. C. Roe, Comparative efficacy of Adderall and methylphenidate in attention-deficit/hyperactivity disorder A meta-analysis, J Clin Psychopharmacol 22 (2002), 468-473.
17. M.J. Manos, E.J. Short and R.L. Findling, Differential effectiveness of methylphenidate and Adderall in school-age youths with attention-deficit/ hyperactivity disorder, J Am Acad Child Adolesc Psychiatry 38 (1999), 813-819.
18. R.T. Brown and A. LaRosa, Recent developments in the pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD), Prof Psychol Res Pr 33 (2002), 591-595.
19. J.J. McGough, J. Biederman, S.B. Wigal et al., Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD, J Am Acad Adolesc Psychiatry 44 (2005), 530-538.
20. C.K. Conners, Conners' Rating Scales-Revised (CRS-R), North Tonawanda, NY: Multi-Health Systems, Inc, 1997.